List of Tables
Table 1. Real-World Evidence in Healthcare Market Trends
Table 2. Real-World Evidence in Healthcare Market Drivers & Opportunity
Table 3. Real-World Evidence in Healthcare Market Challenges
Table 4. Real-World Evidence in Healthcare Market Restraints
Table 5. Global Real-World Evidence in Healthcare Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Real-World Evidence in Healthcare Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Real-World Evidence in Healthcare Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Real-World Evidence in Healthcare Product Type
Table 9. Key Companies Time to Begin Mass Production of Real-World Evidence in Healthcare
Table 10. Global Real-World Evidence in Healthcare Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real-World Evidence in Healthcare as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Real-World Evidence in Healthcare Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Real-World Evidence in Healthcare Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Real-World Evidence in Healthcare Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Real-World Evidence in Healthcare Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Real-World Evidence in Healthcare Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Real-World Evidence in Healthcare Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Real-World Evidence in Healthcare Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Real-World Evidence in Healthcare Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Real-World Evidence in Healthcare Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Real-World Evidence in Healthcare Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Real-World Evidence in Healthcare Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Real-World Evidence in Healthcare Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Real-World Evidence in Healthcare Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Real-World Evidence in Healthcare Sales Value by Region (2019-2024) & (%)
Table 27. Global Real-World Evidence in Healthcare Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Real-World Evidence in Healthcare Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Real-World Evidence in Healthcare Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Real-World Evidence in Healthcare Sales Value, (2025-2030) & (US$ Million)
Table 31. Anthem Basic Information List
Table 32. Anthem Description and Business Overview
Table 33. Anthem Real-World Evidence in Healthcare Products, Services and Solutions
Table 34. Revenue (US$ Million) in Real-World Evidence in Healthcare Business of Anthem (2019-2024)
Table 35. Anthem Recent Developments
Table 36. IQVIA Basic Information List
Table 37. IQVIA Description and Business Overview
Table 38. IQVIA Real-World Evidence in Healthcare Products, Services and Solutions
Table 39. Revenue (US$ Million) in Real-World Evidence in Healthcare Business of IQVIA (2019-2024)
Table 40. IQVIA Recent Developments
Table 41. ICON Basic Information List
Table 42. ICON Description and Business Overview
Table 43. ICON Real-World Evidence in Healthcare Products, Services and Solutions
Table 44. Revenue (US$ Million) in Real-World Evidence in Healthcare Business of ICON (2019-2024)
Table 45. ICON Recent Developments
Table 46. PPD Basic Information List
Table 47. PPD Description and Business Overview
Table 48. PPD Real-World Evidence in Healthcare Products, Services and Solutions
Table 49. Revenue (US$ Million) in Real-World Evidence in Healthcare Business of PPD (2019-2024)
Table 50. PPD Recent Developments
Table 51. Clinigen Group Basic Information List
Table 52. Clinigen Group Description and Business Overview
Table 53. Clinigen Group Real-World Evidence in Healthcare Products, Services and Solutions
Table 54. Revenue (US$ Million) in Real-World Evidence in Healthcare Business of Clinigen Group (2019-2024)
Table 55. Clinigen Group Recent Developments
Table 56. Cognizant Technology Solutions Corporation Basic Information List
Table 57. Cognizant Technology Solutions Corporation Description and Business Overview
Table 58. Cognizant Technology Solutions Corporation Real-World Evidence in Healthcare Products, Services and Solutions
Table 59. Revenue (US$ Million) in Real-World Evidence in Healthcare Business of Cognizant Technology Solutions Corporation (2019-2024)
Table 60. Cognizant Technology Solutions Corporation Recent Developments
Table 61. Oracle Basic Information List
Table 62. Oracle Description and Business Overview
Table 63. Oracle Real-World Evidence in Healthcare Products, Services and Solutions
Table 64. Revenue (US$ Million) in Real-World Evidence in Healthcare Business of Oracle (2019-2024)
Table 65. Oracle Recent Developments
Table 66. Parexel Basic Information List
Table 67. Parexel Description and Business Overview
Table 68. Parexel Real-World Evidence in Healthcare Products, Services and Solutions
Table 69. Revenue (US$ Million) in Real-World Evidence in Healthcare Business of Parexel (2019-2024)
Table 70. Parexel Recent Developments
Table 71. PerkinElmer Basic Information List
Table 72. PerkinElmer Description and Business Overview
Table 73. PerkinElmer Real-World Evidence in Healthcare Products, Services and Solutions
Table 74. Revenue (US$ Million) in Real-World Evidence in Healthcare Business of PerkinElmer (2019-2024)
Table 75. PerkinElmer Recent Developments
Table 76. SAS Institute Basic Information List
Table 77. SAS Institute Description and Business Overview
Table 78. SAS Institute Real-World Evidence in Healthcare Products, Services and Solutions
Table 79. Revenue (US$ Million) in Real-World Evidence in Healthcare Business of SAS Institute (2019-2024)
Table 80. SAS Institute Recent Developments
Table 81. UnitedHealth Group Basic Information List
Table 82. UnitedHealth Group Description and Business Overview
Table 83. UnitedHealth Group Real-World Evidence in Healthcare Products, Services and Solutions
Table 84. Revenue (US$ Million) in Real-World Evidence in Healthcare Business of UnitedHealth Group (2019-2024)
Table 85. UnitedHealth Group Recent Developments
Table 86. Flatiron Health Basic Information List
Table 87. Flatiron Health Description and Business Overview
Table 88. Flatiron Health Real-World Evidence in Healthcare Products, Services and Solutions
Table 89. Revenue (US$ Million) in Real-World Evidence in Healthcare Business of Flatiron Health (2019-2024)
Table 90. Flatiron Health Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Real-World Evidence in Healthcare Downstream Customers
Table 94. Real-World Evidence in Healthcare Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Real-World Evidence in Healthcare Product Picture
Figure 2. Global Real-World Evidence in Healthcare Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Real-World Evidence in Healthcare Sales Value (2019-2030) & (US$ Million)
Figure 4. Real-World Evidence in Healthcare Report Years Considered
Figure 5. Global Real-World Evidence in Healthcare Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Real-World Evidence in Healthcare Revenue in 2023
Figure 7. Real-World Evidence in Healthcare Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Service Picture
Figure 9. Data Set Picture
Figure 10. Global Real-World Evidence in Healthcare Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Real-World Evidence in Healthcare Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Drug Development and Approval
Figure 13. Product Picture of Development and Approval of Medical Devices
Figure 14. Global Real-World Evidence in Healthcare Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Real-World Evidence in Healthcare Sales Value Market Share by Application, 2023 & 2030
Figure 16. North America Real-World Evidence in Healthcare Sales Value (2019-2030) & (US$ Million)
Figure 17. North America Real-World Evidence in Healthcare Sales Value by Country (%), 2023 VS 2030
Figure 18. Europe Real-World Evidence in Healthcare Sales Value (2019-2030) & (US$ Million)
Figure 19. Europe Real-World Evidence in Healthcare Sales Value by Country (%), 2023 VS 2030
Figure 20. Asia Pacific Real-World Evidence in Healthcare Sales Value (2019-2030) & (US$ Million)
Figure 21. Asia Pacific Real-World Evidence in Healthcare Sales Value by Country (%), 2023 VS 2030
Figure 22. South America Real-World Evidence in Healthcare Sales Value (2019-2030) & (US$ Million)
Figure 23. South America Real-World Evidence in Healthcare Sales Value by Country (%), 2023 VS 2030
Figure 24. Middle East & Africa Real-World Evidence in Healthcare Sales Value (2019-2030) & (US$ Million)
Figure 25. Middle East & Africa Real-World Evidence in Healthcare Sales Value by Country (%), 2023 VS 2030
Figure 26. Key Countries/Regions Real-World Evidence in Healthcare Sales Value (%), (2019-2030)
Figure 27. United States Real-World Evidence in Healthcare Sales Value, (2019-2030) & (US$ Million)
Figure 28. United States Real-World Evidence in Healthcare Sales Value by Type (%), 2023 VS 2030
Figure 29. United States Real-World Evidence in Healthcare Sales Value by Application (%), 2023 VS 2030
Figure 30. Europe Real-World Evidence in Healthcare Sales Value, (2019-2030) & (US$ Million)
Figure 31. Europe Real-World Evidence in Healthcare Sales Value by Type (%), 2023 VS 2030
Figure 32. Europe Real-World Evidence in Healthcare Sales Value by Application (%), 2023 VS 2030
Figure 33. China Real-World Evidence in Healthcare Sales Value, (2019-2030) & (US$ Million)
Figure 34. China Real-World Evidence in Healthcare Sales Value by Type (%), 2023 VS 2030
Figure 35. China Real-World Evidence in Healthcare Sales Value by Application (%), 2023 VS 2030
Figure 36. Japan Real-World Evidence in Healthcare Sales Value, (2019-2030) & (US$ Million)
Figure 37. Japan Real-World Evidence in Healthcare Sales Value by Type (%), 2023 VS 2030
Figure 38. Japan Real-World Evidence in Healthcare Sales Value by Application (%), 2023 VS 2030
Figure 39. South Korea Real-World Evidence in Healthcare Sales Value, (2019-2030) & (US$ Million)
Figure 40. South Korea Real-World Evidence in Healthcare Sales Value by Type (%), 2023 VS 2030
Figure 41. South Korea Real-World Evidence in Healthcare Sales Value by Application (%), 2023 VS 2030
Figure 42. Southeast Asia Real-World Evidence in Healthcare Sales Value, (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Real-World Evidence in Healthcare Sales Value by Type (%), 2023 VS 2030
Figure 44. Southeast Asia Real-World Evidence in Healthcare Sales Value by Application (%), 2023 VS 2030
Figure 45. India Real-World Evidence in Healthcare Sales Value, (2019-2030) & (US$ Million)
Figure 46. India Real-World Evidence in Healthcare Sales Value by Type (%), 2023 VS 2030
Figure 47. India Real-World Evidence in Healthcare Sales Value by Application (%), 2023 VS 2030
Figure 48. Real-World Evidence in Healthcare Industrial Chain
Figure 49. Real-World Evidence in Healthcare Manufacturing Cost Structure
Figure 50. Channels of Distribution (Direct Sales, and Distribution)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
